Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/04/2025 ,inter alia, to consider and approve 1. To consider and approve ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Ltd (formerly Roxy Exports Limited, BSE scrip code 539561) has called a board meeting on Monday, April 7, 2025, at its registered office in Andheri East, Mumbai. The main agenda is to consider and approve the number of shares, issue price, and entitlement ratio for a proposed Rights Issue to existing shareholders. The board will also fix a record date to identify eligible shareholders for the issue. The trading window for dealing in company shares is already closed from April 1, 2025 and will remain shut until 48 hours after the audited results for FY ending March 31, 2025 are declared.
If the Rights Issue is approved, existing shareholders will get an opportunity to buy additional shares, which may lead to short-term share price pressure but brings fresh capital to the company. Investors should watch for the size and price of the issue after April 7, as it will determine the dilution impact.